[Federal Register: April 27, 1999 (Volume 64, Number 80)] [Notices] [Page 22612-22613] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr27ap99-55] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Vaccine Advisory Committee (NVAC), Subcommittee on Future Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on Vaccine Safety: Meetings In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following Federal advisory committee meetings. NAME: National Vaccine Advisory Committee (NVAC). TIMES AND DATES: 9 a.m.-2 p.m., May 13, 1999; 8:30 a.m.-1 p.m., May 14, 1999. PLACE: Hubert H. Humphrey Building, Room 505A, 200 Independence Avenue, SW, Washington, DC 20201. STATUS: Open to the public, limited only by the space available. NOTICE: In the interest of security, the Department has instituted stringent procedures for entrance to the Hubert H. Humphrey Building by non-government employees. Thus, persons without a government identification card should plan to arrive at the building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m. so they can be escorted to the meeting. Entrance to the meeting at other times during the day cannot be assured. PURPOSE: This committee advises and makes recommendations to the Director of the National Vaccine Program on matters related to the Program responsibilities. MATTERS TO BE DISCUSSED: Agenda items will include updates on the National Vaccine Program Office (NVPO) activities. There will be a report from the Institute of Medicine on Vaccine Priorities. There will be discussions on: The international measles control and elimination efforts; update on the Advisory Committee on Immunization Practices (ACIP) activities; update on general principles of Vaccine For Children Program (VFC); there will be a follow-up on immunization infrastructure; a discussion on the impact of new vaccines on anti- microbial use. There will be a report from the Assistant Secretary for Health and Surgeon General, update on Healthy People 2010 objectives; an update on pneumococcal and influenza morbidity and mortality. There will be discussions on: Pandemic influenza planning and global vaccine initiatives. There will be [[Page 22613]] reports from the Subcommittee on Future Vaccines, Subcommittee on Immunization Coverage, and the Subcommittee on Vaccine Safety. NAME: Subcommittee on Immunization Coverage. TIME AND DATE: 2 p.m.-5 p.m., May 13, 1999. PLACE: Hubert H. Humphrey Building, Room 505A, 200 Independence Avenue, SW, Washington, DC 20201. STATUS: Open to the public, limited only by the space available. PURPOSE: This subcommittee will identify and propose solutions that provide a multifaceted and holistic approach to reducing barriers that result in low immunization coverage for children. MATTERS TO BE DISCUSSED: This subcommittee will discuss: adult immunization in non-traditional settings; revisions of the Standards on Adult Immunization; the status of activities to sustain immunization coverage, an update on morbidity and mortality for influenza and pneumococcal disease; draft guidelines for implementation of new vaccines; the Children's Health Insurance Program (CHIP); and a draft statement on adolescent immunizations. NAME: Subcommittee on Future Vaccines. TIME AND DATE: 2 p.m.-5 p.m., May 13, 1999. PLACE: Hubert H. Humphrey Building, Room 305, 200 Independence Avenue, SW, Washington, DC 20201. STATUS: Open to the public, limited only by the space available. PURPOSE: The Subcommittee on Future Vaccines will develop policy options and guide national activities which will lead to accelerated development, licensure, and best use of new vaccines in the simplest possible immunization schedules. MATTERS TO BE DISCUSSED: This subcommittee will hold discussions regarding the IOM report on vaccines priorities. There will be a discussion on orphan vaccines and global vaccines, and an update on the status of the paper ``Lessons Learned From A Review Of The Development Of Selected Vaccines''. NAME: Subcommittee on Vaccine Safety. TIME AND DATE: 2 p.m.-5 p.m., May 13, 1999. PLACE: Hubert H. Humphrey Building, Room 325, 200 Independence Avenue, SW, Washington, DC 20201. STATUS: Open to the public, limited only by the space available. PURPOSE: This subcommittee will review issues relevant to vaccine safety and adverse reactions to vaccines. MATTERS TO BE DISCUSSED: This subcommittee will discuss the mission of the Vaccine Safety Subcommittee, developing priorities for the Vaccine Safety Action Plan. There will be a discussion on the DHHS Communication Coalition. Agenda items are subject to change as priorities dictate. CONTACT PERSON FOR MORE INFORMATION: Felecia D. Pearson, Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, M/S A11, Atlanta, Georgia 30333, telephone 404/639-4450. Director, Management Analysis Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 21, 1999. Carolyn J. Russell, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 99-10467 Filed 4-26-99; 8:45 am] BILLING CODE 4163-18-P